API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2024/04/09/2860412/0/en/Notable-Labs-Presents-the-Design-Plan-for-the-PPMP-Enabled-Phase-2-Trial-with-Volasertib-for-Relapsed-Refractory-AML-at-AACR-2024.html
https://www.globenewswire.com//news-release/2024/02/22/2833635/0/en/Notable-Advances-Volasertib-Phase-2-Program-Utilizing-Proprietary-Predictive-Precision-Medicine-Platform-Guided-Enrollment.html
https://www.prnewswire.com/news-releases/oncoheroes-biosciences-inc-and-boehringer-ingelheim-international-gmbh-sign-exclusive-licensing-agreement-for-volasertib-300917504.html